4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-011917
CEO and CFO bought 5,000 shares at $12.42 ($62,100)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-04-11 | Purchase | +5,000 | $12.42 | $62,100 | 5,271,177 | D |
| Open-market purchases · 5,000 sh · avg $12.42 · $62,100 | |||||||
Loading xslF345X04/ownership.xml…